Literature DB >> 9067452

Expression of presenilin-1 and -2 mRNAs in rat and Alzheimer's disease brains.

K Takami1, K Terai, A Matsuo, D G Walker, P L McGeer.   

Abstract

Recently, new genetic linkages have been identified for early-onset familial Alzheimer's disease (AD). Mutations have been found in the presenilin (PS)-1 (S182) gene on chromosome 14 and the PS-2 (STM2/E5-a) gene on chromosome 1. We have investigated the distribution of gene expression of both presenilins in normal rat brain, and in human control and AD cases using in situ hybridization histochemistry. In normal rat brain, intense PS-1 mRNA expression was observed predominantly in neurons, particularly hippocampal pyramidal and dentate granular neurons and cerebellar Purkinje and granular neurons. The distribution of intensely expressing PS-2 mRNA cells was similar to that of PS-1, but additional groups in the brain stem and cortex were identified. Faint but significant mRNA expression of both PS genes was detected in white matter. In control human cases, the same neuronal cell types as seen in rat brain expressed both PS mRNAs in the hippocampus and cerebellum. In AD cases, the expression of both mRNAs was markedly decreased in the hippocampus but not in the cerebellum. In addition, PS-2 hybridization showed increased mRNA expression in astrocyte-like cells in affected areas of AD cases. The present data indicate that the PS genes may play important roles in specific neurons in normal brain, and that the decreased expression in neurons in sporadic AD brain may bear some relationship to the pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9067452     DOI: 10.1016/s0006-8993(96)01274-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  Rosuvastatin and thapsigargin modulate γ-secretase gene expression and APP processing in a human neuroglioma model.

Authors:  Alessio Crestini; Paola Piscopo; Mariavittoria Iazeolla; Diego Albani; Roberto Rivabene; Gianluigi Forloni; Annamaria Confaloni
Journal:  J Mol Neurosci       Date:  2010-10-28       Impact factor: 3.444

Review 2.  Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature.

Authors:  Tony Wyss-Coray; Joseph Rogers
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

3.  Expression of presenilin 1 mRNA in rat peripheral organs and brain.

Authors:  C Nilsberth; J Luthman; L Lannfelt; M Schultzberg
Journal:  Histochem J       Date:  1999-08

4.  Na,K-ATPase mRNA levels and plaque load in Alzheimer's disease.

Authors:  N B Chauhan; J M Lee; G J Siegel
Journal:  J Mol Neurosci       Date:  1997-12       Impact factor: 3.444

5.  Interaction of presenilins with the filamin family of actin-binding proteins.

Authors:  W Zhang; S W Han; D W McKeel; A Goate; J Y Wu
Journal:  J Neurosci       Date:  1998-02-01       Impact factor: 6.167

6.  Early presynaptic and postsynaptic calcium signaling abnormalities mask underlying synaptic depression in presymptomatic Alzheimer's disease mice.

Authors:  Shreaya Chakroborty; Joyce Kim; Corinne Schneider; Christopher Jacobson; Jordi Molgó; Grace E Stutzmann
Journal:  J Neurosci       Date:  2012-06-13       Impact factor: 6.167

Review 7.  Molecular basis of etiological implications in Alzheimer's disease: focus on neuroinflammation.

Authors:  Rituraj Niranjan
Journal:  Mol Neurobiol       Date:  2013-02-19       Impact factor: 5.590

8.  Brain regional correlation of amyloid-β with synapses and apolipoprotein E in non-demented individuals: potential mechanisms underlying regional vulnerability to amyloid-β accumulation.

Authors:  Mitsuru Shinohara; Ronald C Petersen; Dennis W Dickson; Guojun Bu
Journal:  Acta Neuropathol       Date:  2013-01-31       Impact factor: 17.088

9.  REM sleep deprivation induces changes of down regulatory antagonist modulator (DREAM) expression in the ventrobasal thalamic nuclei of sprague-dawley rats.

Authors:  Rosfaiizah Siran; Asma Hayati Ahmad; Che Badariah Abdul Aziz; Zalina Ismail
Journal:  J Physiol Biochem       Date:  2014-09-15       Impact factor: 4.158

10.  Clusterin levels are increased in Alzheimer's disease and influence the regional distribution of Aβ.

Authors:  J Scott Miners; Polly Clarke; Seth Love
Journal:  Brain Pathol       Date:  2016-07-08       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.